Top accelerator startups

14,448 startups · 29 programs

RNARevive

RNARevive is developing a next-generation RNA platform that enables long-lasting, low-dose protein therapeutics. Our lead candidates tackle the anti-aging and longevity space, targeting osteoporosis, age-related macular degeneration (AMD), and liver diseases.

1signal of 100 · rising 1
  • went through Plug and PlayProgram · this site+1

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from Plug and Play

All of Plug and Play

Programs

Programs RNARevive went through
ProgramCohortSource
Plug and PlayNot statedPlug and Play Page

About RNARevive

RNArevive Therapeutics is a biotechnology company specializing in the development of a next-generation self-amplifying RNA (saRNA) platform designed to enable durable, low-dose protein therapeutics in vivo. This innovative technology addresses key challenges of traditional biologics and mRNA therapies, such as limited durability, high manufacturing costs, and frequent dosing requirements. The platform is applied across chronic and specialty disease areas, including bone health, ophthalmology, and liver diseases, aiming to reduce patient and healthcare system burdens through long-lasting protein expression. By integrating advanced RNA engineering with scalable manufacturing and delivery solutions, RNArevive Therapeutics contributes to the advancement of RNA-based medicines. Collaborative efforts with academic and industry partners support the development of a versatile platform capable of addressing multiple therapeutic indications, positioning the company as an important innovator in the life sciences sector.

Category
Other
Location
Canada
Checked
7h ago

RNARevive: questions

Which accelerators did RNARevive go through?

RNARevive is listed by Plug and Play.

Where is RNARevive based?

RNARevive lists Canada as its location on Plug and Play's page.